Skip to main content

FISIOLOGIA DE INTERACTORES DE RECEPTORES AMPA (TARPS Y CPT1C) EN NEURONAS Y GLIA

PID2020-119932GB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Beta-hydroxybutyrate counteracts the deleterious effects of a saturated high-fat diet on synaptic AMPAR receptors and cognitive performance

  • Rojas, Rocío|||0000-0002-0509-1023
  • Griñán-Ferré, Christian|||0000-0002-5424-9130
  • Castellanos, Aida
  • Griego, Ernesto
  • Martínez, Marc
  • de Dios Navarro-López, Juan
  • Jiménez-Díaz, Lydia|||0000-0001-9121-0334
  • Rodríguez Álvarez, José|||0000-0001-8582-8082
  • Soto del Cerro, David
  • Castillo, Pablo E.
  • Pallàs, Mercè|||0000-0003-3095-4254
  • Casals, Nuria|||0000-0002-6719-4300
  • Fadó, Rut|||0000-0002-3293-2342
The ketogenic diet -high in fat and low in carbohydrates- and intermittent fasting have gained popularity not only for weight management but also for their potential to delay cognitive decline associated with neurodegenerative diseases and aging. However, adherence to these diets remains low due to their restrictive nature and undesirable side effects. Both dietary approaches stimulate hepatic production of ketone bodies, primarily β-hydroxybutyrate (BHB), which serves as an alternative energy source for neurons. Here, we investigated whether BHB supplementation could mitigate AMPA receptor trafficking impairments, synaptic dysfunction, and cognitive decline induced by metabolic challenges such as a saturated fat-rich diet. Our results show that, in cultured primary cortical neurons, exposure to palmitic acid decreases surface levels of glutamate GluA1-containing AMPA receptors, whereas unsaturated fatty acids and BHB increase these levels. Furthermore, physiological concentrations of BHB (1-2 mM) countered the adverse effects of palmitic acid on synaptic GluA1 and GluA2 levels in hippocampal neurons, restoring AMPA receptor-mediated synaptic transmission. In hippocampal slices, BHB also reversed palmitate-induced impairments in excitability and synaptic plasticity (long-term potentiation; LTP). Additionally, daily intragastric administration of BHB (100 mg/kg/day for two months) prevented deficits in recognition and spatial memory induced by a saturated fat-rich diet (49% of calories from fat) in mice. In summary, our findings underscore the significant impact of fatty acids and ketone bodies on AMPA receptor abundance, synaptic function, and neuroplasticity, shedding light on the potential use of BHB as a dietary supplement to counteract cognitive impairments linked to metabolic diseases.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

First-in-class SAM-competitive G9a inhibitor FLAV-27 as a disease-modifying therapy for Alzheimer disease

  • Bellver-Sanchís, Aina
  • Valle-García, David
  • Barbaraci, Carla
  • Romero-Becerra, Fernando
  • Singh, Rohit Kumar
  • Jarne-Ferrer, Júlia
  • Vasilopoulou, Foteini
  • Irisarri, Alba
  • Martínez-Fernández, Carmen (Universitat de Barcelona)
  • Fafián-Labora, J. A.
  • Arufe, M.C.
  • Wüst, Carolin
  • Castellanos, Aida
  • Soto, David
  • Casals, Núria
  • Fadó, Rut
  • Pocock, Jennifer M.
  • Navarro, Gemma
  • Val, Cristina
  • Brea, José M.
  • Loza, María Isabel
  • Lleó, Albert
  • Fortea, Juan
  • Alcolea, Daniel
  • Pérez-Bosque, Anna
  • Miró, Lluïsa
  • Pérez, Belén
  • Rashid, Sajid
  • Ali, Muhammad
  • Saqib, Manahil
  • Lí Carbó, Marcel
  • Guerrero, Ana
  • Vázquez, Santiago
  • Choudhary, Bhanwar Singh
  • Dai, Shaodong
  • Escolano, Carmen
  • Franco, Rafael
  • Pallàs, Mercé
  • Griñán-Ferré, Christian
[Abstract] Alzheimer's disease (AD) is characterized by a progressive cognitive decline involving a multifactorial pathophysiology, including epigenetic dysregulation. Here, we report the discovery and preclinical validation of FLAV-27, a first-in-class, S-adenosyl-l-methionine (SAM)-competitive, brain-penetrant, and selective inhibitor of the histone methyltransferase G9a. Unlike prior G9a/GLP inhibitors, FLAV-27 exhibits subnanomolar potency, over 30-fold selectivity, and robust central nervous system bioavailability. Structural studies confirm a unique SAM-binding mode that confers superior specificity and avoids off-target effects. FLAV-27 reduces amyloid beta (Aβ) and p-tau aggregation and restores neuritic complexity in vitro. In Caenorhabditis elegans, it improves mobility, lifespan, and mitochondrial respiration. In mouse models of both late-onset AD (SAMP8) and early-onset AD (5xFAD), FLAV-27 rescues memory performance, social behavior, and synaptic structure. Multi-omics analyses reveal a global reprogramming of H3K9me2/H3K18me-mediated repression, reduced ferroptosis vulnerabilities, and normalization of AD-linked biomarkers, including SMOC1, H3K9me2, and p-Tau181, in the plasma and brain. Our findings position FLAV-27 as a promising epigenetic therapeutic with disease-modifying potential and translational biomarker alignment in AD., This study was supported by Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación MICIU/AEI/10.13039/501100011033, and European Union NextGenerationEU/PRTR and FEDER, UE (PID2022-139016OA-I00, PDC2022-133441-I00 to M.P., PID2022-1380790B-I00 to C.E. and PID2020-119932GB-I00 to D.S.), María de Maeztu (MDM-2017-0729 to Institut de Neurociencies, Universitat de Barcelona) and by AGAUR (Generalitat de Catalunya) 2021 SGR 00357. This study was co-financed by Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya 2023 (Product 0092; Llavor 005 and Llavor 007 to CGF). ABS. acknowledges the Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) for her FI-SDUR fellowship (2021FISDU 00182). NIDDK R01 230857 GRANT to SD. Financial support was provided for F.R.-B. (PREP2022-000196 Ministerio de Ciencia e Innovación). R.K.S. were supported by NIH R01 DK137056. The x-ray crystallography was performed on APS beam time award from the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science user facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. We thank Jay Nix of ALS beamline 4.2.2 for help with data collection. The ALS is supported by the Director, Office of Science, Office of Basic Energy Sciences, Materials Sciences Division of the US Department of Energy under Contract No. DE-AC03-76SF00098 at Lawrence Berkeley National Laboratory. C. elegans strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Synaptic proteome diversity is shaped by the levels of glutamate receptors and their regulatory proteins

  • Reig-Viader, Rita
  • del Castillo-Berges, Diego
  • Burgas-Pau, Albert
  • Arco-Alonso, Daniel
  • Zerpa-Rios, Oriana
  • Ramos-Vicente, David
  • Picañol, Javier
  • Castellanos, Aida
  • Soto, David
  • Roher, Nerea
  • Sindreu, Carlos
  • Bayés, Àlex
Synapses formed by equivalent pairs of pre- and postsynaptic neurons have similar electrophysiological characteristics, belonging to the same type. However, these are generally confined to microscopic brain regions, precluding their proteomic analysis. This fact has greatly limited our ability to investigate the molecular basis of synaptic physiology. We introduce a procedure to characterise the synaptic proteome of microscopic brain regions and explore the molecular diversity among the synapses forming the trisynaptic circuit in the mouse hippocampus. While we observe a remarkable proteomic diversity among these synapses, we also report that proteins involved in the regulation of the function of glutamate receptors are differentially expressed in all of them. Moreover, neuron-specific gene expression programs would contribute to their regulation. Here, we introduce a combined proteomics and transcriptomics analysis uncovering a previously unrecognized neuron-specific control of synaptic proteome diversity, directed towards the regulation of glutamate receptors and their regulatory proteins., RRV, DdCB, OZR and AB financial support was provided by: PID2024-160538OB-I00, PID2021-124411OB-I00 and RTI2018-097037-B-I00 (MINECO/MCI/AEI/FEDER, EU), Award AC17/00005 by ISCIII through AES2017 and within the NEURON framework, Ramón y Cajal Fellowship (RYC-2011-08391p), IEDI-2017-00822, Universitat Autònoma de Barcelona and AGAUR (2017 SGR 1776 and 2021 SGR 01005). DdCB thanks AGAUR/Generalitat de Catalunya/FEDER, EU for ‘Ajuts per a la contractació de personal investigador novel (FI)’ Ref.2020FI_B00130. All authors thank the CERCA Programme/Generalitat de Catalunya for institutional support. JP, AC and DS were supported by grant from Ministerio de Universidades, Ciencia y Innovación Innovación (PID2020-119932GB-I00, MCIN/ AEI /10.13039/5011000011033) and the María de Maeztu (MDM-2017-0729 to Institut de Neurociencies, Universitat de Barcelona)., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publication Artículo científico (JournalArticle)

Synaptic proteome diversity is shaped by the levels of glutamate receptors and their regulatory proteins

  • Reig-Viader, Rita
  • del Castillo-Berges, Diego
  • Burgas-Pau, Albert
  • Arco-Alonso, Daniel
  • Zerpa-Rios, Oriana
  • Ramos-Vicente, David
  • Picañol, Javier
  • Castellanos, Aida
  • Soto, David
  • Roher, Nerea
  • Sindreu, Carlos
  • Bayés, Àlex
Synapses formed by equivalent pairs of pre- and postsynaptic neurons have similar electrophysiological characteristics, belonging to the same type. However, these are generally confined to microscopic brain regions, precluding their proteomic analysis. This fact has greatly limited our ability to investigate the molecular basis of synaptic physiology. We introduce a procedure to characterise the synaptic proteome of microscopic brain regions and explore the molecular diversity among the synapses forming the trisynaptic circuit in the mouse hippocampus. While we observe a remarkable proteomic diversity among these synapses, we also report that proteins involved in the regulation of the function of glutamate receptors are differentially expressed in all of them. Moreover, neuron-specific gene expression programs would contribute to their regulation. Here, we introduce a combined proteomics and transcriptomics analysis uncovering a previously unrecognized neuron-specific control of synaptic proteome diversity, directed towards the regulation of glutamate receptors and their regulatory proteins., RRV, DdCB, OZR and AB financial support was provided by: PID2024-160538OB-I00, PID2021-124411OB-I00 and RTI2018-097037-B-I00 (MINECO/MCI/AEI/FEDER, EU), Award AC17/00005 by ISCIII through AES2017 and within the NEURON framework, Ramón y Cajal Fellowship (RYC-2011-08391p), IEDI-2017-00822, Universitat Autònoma de Barcelona and AGAUR (2017 SGR 1776 and 2021 SGR 01005). DdCB thanks AGAUR/Generalitat de Catalunya/FEDER, EU for ‘Ajuts per a la contractació de personal investigador novel (FI)’ Ref.2020FI_B00130. All authors thank the CERCA Programme/Generalitat de Catalunya for institutional support. JP, AC and DS were supported by grant from Ministerio de Universidades, Ciencia y Innovación Innovación (PID2020-119932GB-I00, MCIN/ AEI /10.13039/5011000011033) and the María de Maeztu (MDM-2017-0729 to Institut de Neurociencies, Universitat de Barcelona)., info:eu-repo/semantics/publishedVersion